Loading...

bioAffinity Technologies, Inc.

BIAFW•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.23
$0.08(55.13%)

bioAffinity Technologies, Inc. (BIAFW) Stock Overview

Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.7/100

Key Financials

Market Cap10.8M
P/E Ratio-0.56
EPS (TTM)N/A
ROE-3.68%

AI Price Forecasts

1 Week$0.17
1 Month$0.50
3 Months$0.97
1 Year Target$0.57

BIAFW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of bioAffinity Technologies, Inc. (BIAFW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.56 and a market capitalization of 10.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for BIAFWStats details for BIAFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BIAFWAnalyst Recommendations details for BIAFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

CEO

Ms. Maria Zannes J.D.

Employees

57

Headquarters

3300 Nacogdoches Road, San Antonio, DE

Founded

1970

Frequently Asked Questions

;